AstraZeneca last week told investors that its China president, Leon Wang, was “cooperating with an ongoing investigation ...
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
Deutsche Bank upgraded AstraZeneca (AZN) to Hold from Sell with an unchanged price target of 10,500 GBp. The firm cites valuation for the ...
AstraZeneca has emphasized its continued commitment to delivering medicines in China, despite speculative media reports about ...
China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback